Infections occur when bacteria colonize the surface of the implant, creating a resistant biofilm on the implant surface, nullifing the body’s antibody response. Spangehl estimated that the treatment of such infections cost over $200 million in the US alone in 1999.

The Orthobond AI-SAMP anti-infective technology could help prevent the full range of orthopedic infections by killing bacteria as they contact the pin surface and preventing biofilm formation pre- and post-operatively.

For more information, download our white paper on AI-SAMP.